48,466
edits
Difference between revisions of "Cancer staging systems"
Jump to navigation
Jump to search
→Tumour stage
| Line 75: | Line 75: | ||
***[[Hepatocellular carcinoma]].<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf]. Accessed on: 6 April 2012.</ref> | ***[[Hepatocellular carcinoma]].<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf]. Accessed on: 6 April 2012.</ref> | ||
*[[Margin status]] usually does not affect the tumour stage. | *[[Margin status]] usually does not affect the tumour stage. | ||
**[[Prostate adenocarcinoma]] - on a practical level bladder neck margin positivity usually up stages, see ''[[bladder neck invasion]]''. | |||
===Nodal stage=== | ===Nodal stage=== | ||